• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 RNA 加帽机制及其被核苷酸类似物抑制剂抑制的机制。

A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors.

机构信息

MOE Key Laboratory of Protein Science, School of Medicine, Tsinghua University, Beijing, China.

MOE Key Laboratory of Protein Science, School of Medicine, Tsinghua University, Beijing, China; Tsinghua University-Peking University Joint Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China.

出版信息

Cell. 2022 Nov 10;185(23):4347-4360.e17. doi: 10.1016/j.cell.2022.09.037. Epub 2022 Oct 4.

DOI:10.1016/j.cell.2022.09.037
PMID:
36335936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9531661/
Abstract

Decoration of cap on viral RNA plays essential roles in SARS-CoV-2 proliferation. Here, we report a mechanism for SARS-CoV-2 RNA capping and document structural details at atomic resolution. The NiRAN domain in polymerase catalyzes the covalent link of RNA 5' end to the first residue of nsp9 (termed as RNAylation), thus being an intermediate to form cap core (GpppA) with GTP catalyzed again by NiRAN. We also reveal that triphosphorylated nucleotide analog inhibitors can be bonded to nsp9 and fit into a previously unknown "Nuc-pocket" in NiRAN, thus inhibiting nsp9 RNAylation and formation of GpppA. S-loop (residues 50-KTN-52) in NiRAN presents a remarkable conformational shift observed in RTC bound with sofosbuvir monophosphate, reasoning an "induce-and-lock" mechanism to design inhibitors. These findings not only improve the understanding of SARS-CoV-2 RNA capping and the mode of action of NAIs but also provide a strategy to design antiviral drugs.

摘要

病毒 RNA 帽子结构的装饰在 SARS-CoV-2 的增殖中起着至关重要的作用。在这里,我们报告了一种 SARS-CoV-2 RNA 加帽的机制,并记录了原子分辨率的结构细节。聚合酶中的 NiRAN 结构域催化 RNA 5' 端与 nsp9 的第一个残基的共价连接(称为 RNAylation),从而与 GTP 再次由 NiRAN 催化形成帽核(GpppA)。我们还揭示了三磷酸核苷酸类似物抑制剂可以与 nsp9 结合,并适合 NiRAN 中一个以前未知的“Nuc-pocket”,从而抑制 nsp9 RNAylation 和 GpppA 的形成。NiRAN 中的 S-环(50-KTN-52 残基)呈现出与索非布韦单磷酸盐结合的 RTC 中观察到的显著构象变化,这表明存在一种“诱导-锁定”机制来设计抑制剂。这些发现不仅提高了对 SARS-CoV-2 RNA 加帽和 NAI 作用模式的理解,而且为设计抗病毒药物提供了一种策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/ec971f059257/figs6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/074d651aa428/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/75353f73d09e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/161fab077fc8/figs1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/fdad6a66b64a/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/1f9579813373/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/1a73a572caf9/figs2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/f61edb404a81/figs3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/386c3475a6dd/figs4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/8403d45885a6/figs5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/9d4215377581/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/2898e42572e1/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/efa4da3ed9c2/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/ec971f059257/figs6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/074d651aa428/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/75353f73d09e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/161fab077fc8/figs1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/fdad6a66b64a/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/1f9579813373/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/1a73a572caf9/figs2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/f61edb404a81/figs3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/386c3475a6dd/figs4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/8403d45885a6/figs5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/9d4215377581/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/2898e42572e1/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/efa4da3ed9c2/gr6_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0849/9531661/ec971f059257/figs6_lrg.jpg

相似文献

1
A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors.SARS-CoV-2 RNA 加帽机制及其被核苷酸类似物抑制剂抑制的机制。
Cell. 2022 Nov 10;185(23):4347-4360.e17. doi: 10.1016/j.cell.2022.09.037. Epub 2022 Oct 4.
2
Conserved Characteristics of NMPylation Activities of Alpha- and Betacoronavirus NiRAN Domains.α-和β冠状病毒 NiRAN 结构域的 NMPylation 活性的保守特征。
J Virol. 2023 Jun 29;97(6):e0046523. doi: 10.1128/jvi.00465-23. Epub 2023 May 18.
3
The mechanism of RNA capping by SARS-CoV-2.SARS-CoV-2 的 RNA 加帽机制。
Nature. 2022 Sep;609(7928):793-800. doi: 10.1038/s41586-022-05185-z. Epub 2022 Aug 9.
4
Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis.Cryo-EM 结构揭示了 SARS-CoV-2 复制和转录复合物的延伸结构,该结构显示了帽合成中的中间状态。
Cell. 2021 Jan 7;184(1):184-193.e10. doi: 10.1016/j.cell.2020.11.016. Epub 2020 Nov 14.
5
NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain.NMPylation 和 SARS-CoV-2 nsp9 的 NiRAN 结构域去 NMPylation。
Nucleic Acids Res. 2021 Sep 7;49(15):8822-8835. doi: 10.1093/nar/gkab677.
6
Structural and functional insights into the enzymatic plasticity of the SARS-CoV-2 NiRAN domain.SARS-CoV-2 NiRAN 结构域酶学多功能性的结构与功能见解。
Mol Cell. 2023 Nov 2;83(21):3921-3930.e7. doi: 10.1016/j.molcel.2023.10.001. Epub 2023 Oct 26.
7
The mechanism of RNA capping by SARS-CoV-2.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的RNA加帽机制。
Res Sq. 2022 Feb 15:rs.3.rs-1336910. doi: 10.21203/rs.3.rs-1336910/v1.
8
Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading.N7-甲基转移酶和3'-5'外切核糖核酸酶与新冠病毒聚合酶的偶联揭示了加帽和校对机制。
Cell. 2021 Jun 24;184(13):3474-3485.e11. doi: 10.1016/j.cell.2021.05.033. Epub 2021 May 24.
9
A Biochemical and Biophysical Analysis of the Interaction of nsp9 with nsp12 from SARS-CoV-2-Implications for Future Drug Discovery Efforts.一种对 SARS-CoV-2 中 nsp9 与 nsp12 相互作用的生化和生物物理分析 - 对未来药物发现工作的启示。
Proteins. 2024 Nov;92(11):1308-1317. doi: 10.1002/prot.26725. Epub 2024 Jul 3.
10
Structural and functional insights into the enzymatic plasticity of the SARS-CoV-2 NiRAN Domain.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核苷酸转移酶/RNA焦磷酸酶(NiRAN)结构域酶可塑性的结构与功能见解。
bioRxiv. 2023 Sep 26:2023.09.25.558837. doi: 10.1101/2023.09.25.558837.

引用本文的文献

1
Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects.mRNA疫苗应用中的技术突破与进展:全面探索及未来展望
Front Immunol. 2025 Mar 4;16:1524317. doi: 10.3389/fimmu.2025.1524317. eCollection 2025.
2
Drupacine as a potent SARS-CoV-2 replication inhibitor .德鲁帕辛作为一种有效的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)复制抑制剂。
Biosaf Health. 2024 Sep 3;6(5):270-278. doi: 10.1016/j.bsheal.2024.09.001. eCollection 2024 Oct.
3
Covalent inhibition of the SARS-CoV-2 NiRAN domain via an active-site cysteine.

本文引用的文献

1
Structural basis for substrate selection by the SARS-CoV-2 replicase.SARS-CoV-2 复制酶底物选择的结构基础。
Nature. 2023 Feb;614(7949):781-787. doi: 10.1038/s41586-022-05664-3. Epub 2023 Feb 1.
2
The mechanism of RNA capping by SARS-CoV-2.SARS-CoV-2 的 RNA 加帽机制。
Nature. 2022 Sep;609(7928):793-800. doi: 10.1038/s41586-022-05185-z. Epub 2022 Aug 9.
3
The Life of SARS-CoV-2 Inside Cells: Replication-Transcription Complex Assembly and Function.细胞内 SARS-CoV-2 的生活:复制-转录复合物的组装和功能。
通过活性位点半胱氨酸对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核苷酸转移酶/RNA帽甲基转移酶(NiRAN)结构域进行共价抑制。
J Biol Chem. 2025 Apr;301(4):108378. doi: 10.1016/j.jbc.2025.108378. Epub 2025 Mar 4.
4
Transcription Kinetics in the Coronavirus Life Cycle.冠状病毒生命周期中的转录动力学
Wiley Interdiscip Rev RNA. 2025 Jan-Feb;16(1):e70000. doi: 10.1002/wrna.70000.
5
Identification and Ranking of Binding Sites from Structural Ensembles: Application to SARS-CoV-2.从结构集合中识别结合位点并进行排序:在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)中的应用
Viruses. 2024 Oct 22;16(11):1647. doi: 10.3390/v16111647.
6
A Biochemical and Biophysical Analysis of the Interaction of nsp9 with nsp12 from SARS-CoV-2-Implications for Future Drug Discovery Efforts.一种对 SARS-CoV-2 中 nsp9 与 nsp12 相互作用的生化和生物物理分析 - 对未来药物发现工作的启示。
Proteins. 2024 Nov;92(11):1308-1317. doi: 10.1002/prot.26725. Epub 2024 Jul 3.
7
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic.新冠疫情期间和之后对 SARS-CoV-2 发病机制的新认识。
Front Immunol. 2024 Jun 7;15:1363572. doi: 10.3389/fimmu.2024.1363572. eCollection 2024.
8
Inhibition of SARS-CoV-2 Nsp9 ssDNA-Binding Activity and Cytotoxic Effects on H838, H1975, and A549 Human Non-Small Cell Lung Cancer Cells: Exploring the Potential of Leaf Extract for Pulmonary Disease Treatment.抑制 SARS-CoV-2 Nsp9 ssDNA 结合活性和对 H838、H1975 和 A549 人非小细胞肺癌细胞的细胞毒性作用:探索叶提取物治疗肺部疾病的潜力。
Int J Mol Sci. 2024 Jun 1;25(11):6120. doi: 10.3390/ijms25116120.
9
Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice.SARS-CoV-2 感染小鼠中对致病性至关重要的非结构蛋白的突变。
J Virol. 2024 Jul 23;98(7):e0058424. doi: 10.1128/jvi.00584-24. Epub 2024 Jun 18.
10
Characteristics of SARS-CoV-2 Omicron BA.5 variants in Shanghai after ending the zero-COVID policy in December 2022: a clinical and genomic analysis.2022年12月上海结束疫情防控政策后新冠病毒奥密克戎BA.5变异株的特征:一项临床与基因组分析
Front Microbiol. 2024 Mar 28;15:1372078. doi: 10.3389/fmicb.2024.1372078. eCollection 2024.
Annu Rev Biochem. 2022 Jun 21;91:381-401. doi: 10.1146/annurev-biochem-052521-115653.
4
A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase.AT-527 对 SARS-CoV-2 聚合酶的双重作用机制。
Nat Commun. 2022 Feb 2;13(1):621. doi: 10.1038/s41467-022-28113-1.
5
The SARS-CoV-2 RNA polymerase is a viral RNA capping enzyme.SARS-CoV-2 聚合酶是一种病毒 RNA 加帽酶。
Nucleic Acids Res. 2021 Dec 16;49(22):13019-13030. doi: 10.1093/nar/gkab1160.
6
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.SARS-CoV-2 B.1.617.2 德尔塔变异株复制和免疫逃逸。
Nature. 2021 Nov;599(7883):114-119. doi: 10.1038/s41586-021-03944-y. Epub 2021 Sep 6.
7
Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis.莫努匹拉韦诱导的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)诱变机制。
Nat Struct Mol Biol. 2021 Sep;28(9):740-746. doi: 10.1038/s41594-021-00651-0. Epub 2021 Aug 11.
8
NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain.NMPylation 和 SARS-CoV-2 nsp9 的 NiRAN 结构域去 NMPylation。
Nucleic Acids Res. 2021 Sep 7;49(15):8822-8835. doi: 10.1093/nar/gkab677.
9
Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading.N7-甲基转移酶和3'-5'外切核糖核酸酶与新冠病毒聚合酶的偶联揭示了加帽和校对机制。
Cell. 2021 Jun 24;184(13):3474-3485.e11. doi: 10.1016/j.cell.2021.05.033. Epub 2021 May 24.
10
Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit.冠状病毒复制转录复合物:NiRAN-RdRp 亚基对 nsp9 保守位点的关键性和选择性 NMP 化。
Proc Natl Acad Sci U S A. 2021 Feb 9;118(6). doi: 10.1073/pnas.2022310118.